A, K., MJ, L., SN, B., A, P., & AL, M. (2022). Baricitinib for recalcitrant subacute cutaneous lupus erythematosus with concomitant frontal fibrosing alopecia. Clinical and experimental dermatology, 47(4), 787. https://doi.org/10.1111/ced.15044
Chicago Style (17th ed.) CitationA, Kreuter, Licciardi-Fernandez MJ, Burmann SN, Paschos A, and Michalowitz AL. "Baricitinib for Recalcitrant Subacute Cutaneous Lupus Erythematosus with Concomitant Frontal Fibrosing Alopecia." Clinical and Experimental Dermatology 47, no. 4 (2022): 787. https://doi.org/10.1111/ced.15044.
MLA (9th ed.) CitationA, Kreuter, et al. "Baricitinib for Recalcitrant Subacute Cutaneous Lupus Erythematosus with Concomitant Frontal Fibrosing Alopecia." Clinical and Experimental Dermatology, vol. 47, no. 4, 2022, p. 787, https://doi.org/10.1111/ced.15044.